organization · Reporting owner
Ibex Israel Fund 1 LLLP
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BLUE SPHERE CORP.BLSP · Entity 167689 | 10% owner | September 01, 2017 | September 06, 2017 |
| GB SCIENCES INCGBLX · Entity 164724 | 10% owner | October 04, 2016 | October 12, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BLUE SPHERE CORP.
Report date September 01, 2017 · Filed September 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-09-01 transaction · row 1
1 source rowRow 1 · 2017-09-01 · Other · Disposed 324,754 · Balance 0 F1: On September 1, 2017, in connection with the creation of a master-feeder fund structure, Ibex Israel Fund 1 LLLP ("Ibex Israel 1"), formerly known as Lazarus Israel Opportunities Fund LLLP, transferred all of its existing investments, including the common stock and warrants of the Issuer, into Ibex Israel Fund LLLP ("Ibex Israel"), formerly known as Lazarus Israel Opportunities Fund II LLLP, in exchange for partnership interests in Ibex Israel. Ibex Investors LLC ("Ibex Investors"), formerly known as Lazarus Management Company LLC, is the investment adviser of Ibex Israel 1 and Ibex Israel (the "Funds"), and Justin Borus is its manager. Ibex GP LLC ("Ibex GP"), formerly known as Lazarus GP LLC, is the general partner of each of the Funds and Mr. Borus is its manager. F2: The pecuniary interest of Ibex Investors and Mr. Borus in the securities of the Issuer did not change as a result of the transfer and each of Ibex Investors and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.00 · Expires 2021-02-15 | Direct | 0 |
Reported balance
After 2017-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-09-01 · Other · Disposed 96,154 · Balance 0 F1: On September 1, 2017, in connection with the creation of a master-feeder fund structure, Ibex Israel Fund 1 LLLP ("Ibex Israel 1"), formerly known as Lazarus Israel Opportunities Fund LLLP, transferred all of its existing investments, including the common stock and warrants of the Issuer, into Ibex Israel Fund LLLP ("Ibex Israel"), formerly known as Lazarus Israel Opportunities Fund II LLLP, in exchange for partnership interests in Ibex Israel. Ibex Investors LLC ("Ibex Investors"), formerly known as Lazarus Management Company LLC, is the investment adviser of Ibex Israel 1 and Ibex Israel (the "Funds"), and Justin Borus is its manager. Ibex GP LLC ("Ibex GP"), formerly known as Lazarus GP LLC, is the general partner of each of the Funds and Mr. Borus is its manager. F2: The pecuniary interest of Ibex Investors and Mr. Borus in the securities of the Issuer did not change as a result of the transfer and each of Ibex Investors and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 1, 2017, in connection with the creation of a master-feeder fund structure, Ibex Israel Fund 1 LLLP ("Ibex Israel 1"), formerly known as Lazarus Israel Opportunities Fund LLLP, transferred all of its existing investments, including the common stock and warrants of the Issuer, into Ibex Israel Fund LLLP ("Ibex Israel"), formerly known as Lazarus Israel Opportunities Fund II LLLP, in exchange for partnership interests in Ibex Israel. Ibex Investors LLC ("Ibex Investors"), formerly known as Lazarus Management Company LLC, is the investment adviser of Ibex Israel 1 and Ibex Israel (the "Funds"), and Justin Borus is its manager. Ibex GP LLC ("Ibex GP"), formerly known as Lazarus GP LLC, is the general partner of each of the Funds and Mr. Borus is its manager.
F2: The pecuniary interest of Ibex Investors and Mr. Borus in the securities of the Issuer did not change as a result of the transfer and each of Ibex Investors and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds.
GB SCIENCES INC
Report date October 04, 2016 · Filed October 12, 2016 · Amendment
Jointly reported with Ibex Investors LLC, BORUS JUSTIN B, Ibex Microcap Fund LLLP
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 4,000,000 |
Reported balance
After 2016-10-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2016-10-06 · Sale · Disposed 506,479 · Balance 4,000,000 F1: On October 6, 2016 the Reporting Person filed a Form 4 (the "Original Form 4") reporting a sale of an aggregate of 600,000 shares of the Issuer's common stock, which shares were reported as sold by Lazarus Investment Partners LLLP ("Lazarus Partners"). In fact, the sale was of an aggregate of 506,479 shares, of which 84,632 shares were sold directly by Lazarus Partners and 421,847 shares were sold directly by Lazarus Israel Opportunities Fund LLLP ("Lazarus Israel"). This amendment to the Original Form 4 is filed solely for the purpose of reflecting the actual number of shares sold, reflecting the actual number of shares owned following the reported transaction, and clarifying the identity of the direct sellers. F2: The Price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.30 to $0.3175, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Partners and Lazarus Israel (collectively, the "Funds"). The securities reported herein are owned directly by the Funds as follows: (i) Lazarus Israel owns 1,000,000 shares of common stock and 1,000,000 warrants; and (ii) Lazarus Partners owns 3,000,000 shares of common stock and 3,000,000 warrants. Lazarus Management is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Lazarus Management. F4: Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 6, 2016 the Reporting Person filed a Form 4 (the "Original Form 4") reporting a sale of an aggregate of 600,000 shares of the Issuer's common stock, which shares were reported as sold by Lazarus Investment Partners LLLP ("Lazarus Partners"). In fact, the sale was of an aggregate of 506,479 shares, of which 84,632 shares were sold directly by Lazarus Partners and 421,847 shares were sold directly by Lazarus Israel Opportunities Fund LLLP ("Lazarus Israel"). This amendment to the Original Form 4 is filed solely for the purpose of reflecting the actual number of shares sold, reflecting the actual number of shares owned following the reported transaction, and clarifying the identity of the direct sellers.
F2: The Price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.30 to $0.3175, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Partners and Lazarus Israel (collectively, the "Funds"). The securities reported herein are owned directly by the Funds as follows: (i) Lazarus Israel owns 1,000,000 shares of common stock and 1,000,000 warrants; and (ii) Lazarus Partners owns 3,000,000 shares of common stock and 3,000,000 warrants. Lazarus Management is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Lazarus Management.
F4: Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2016 Filed Sep 22, 2016 17:02 UTC | BLUE SPHERE CORP. BLSP · Entity 167689 | OtherCommon Stock | 5,000 | $0.07 | $364.50 |
DisclosureSEC source: 0001140361-16-080560 · doc1.xml · nonDerivative · entry 2 Lazarus Management Co LLC · CIK 0001531964 · 10% owner BORUS JUSTIN B · CIK 0001531960 · 10% owner LAZARUS INVESTMENT PARTNERS LLLP · CIK 0001232118 · 10% owner Lazarus Israel Opportunities Fund LLLP · CIK 0001539956 · 10% owner Lazarus Israel Opportunities Fund II LLLP · CIK 0001639750 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 63,369,895 F1 · shares: Shares of common stock were purchased directly by Lazarus Israel Opportunities Fund II LLLP ("Lazarus Israel II"). F2 · price: The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0727 to $0.0731, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F9 · ownership.nature: This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Israel Opportunities Fund LLLP ("Lazarus Israel I"), Lazarus Israel II and Lazarus Investment Partners LLLP ("Lazarus Partners" and together with Lazarus Israel I and Lazarus Israel II, the "Funds"). The securities reported herein are owned directly by the Funds as follows: (i) Lazarus Israel I owns 42,218,018 shares of common stock and 12,500,000 warrants; (ii) Lazarus Israel II owns 12,481,501 shares of common stock and 2,727,273 warrants; and (iii) Lazarus Partners owns 8,800,476 shares of common stock and 2,272,728 warrants. Lazarus Management is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Lazarus Management. F10 · ownership.nature: Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein. Read SEC document |
| August 05, 2016 Filed Sep 22, 2016 17:02 UTC | BLUE SPHERE CORP. BLSP · Entity 167689 | OtherCommon Stock | 10,000 | $0.07 | $720.00 |
DisclosureSEC source: 0001140361-16-080560 · doc1.xml · nonDerivative · entry 1 Lazarus Management Co LLC · CIK 0001531964 · 10% owner BORUS JUSTIN B · CIK 0001531960 · 10% owner LAZARUS INVESTMENT PARTNERS LLLP · CIK 0001232118 · 10% owner Lazarus Israel Opportunities Fund LLLP · CIK 0001539956 · 10% owner Lazarus Israel Opportunities Fund II LLLP · CIK 0001639750 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 63,364,895 F1 · shares: Shares of common stock were purchased directly by Lazarus Israel Opportunities Fund II LLLP ("Lazarus Israel II"). F9 · ownership.nature: This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Israel Opportunities Fund LLLP ("Lazarus Israel I"), Lazarus Israel II and Lazarus Investment Partners LLLP ("Lazarus Partners" and together with Lazarus Israel I and Lazarus Israel II, the "Funds"). The securities reported herein are owned directly by the Funds as follows: (i) Lazarus Israel I owns 42,218,018 shares of common stock and 12,500,000 warrants; (ii) Lazarus Israel II owns 12,481,501 shares of common stock and 2,727,273 warrants; and (iii) Lazarus Partners owns 8,800,476 shares of common stock and 2,272,728 warrants. Lazarus Management is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Lazarus Management. F10 · ownership.nature: Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.